Maharashtra government has ordered 10,000 vials of investigational drug 'Remdesivir' from a Bangladeshi company Eskayef Pharmaceuticals Ltd.
But, the government had put on hold its decision to purchase Remdesivir drug from Eskayef Pharmaceuticals Ltd, which has neither got a licensing agreement with manufacturer Gilead Sciences nor an approval to sell the drug to any company in India according to Gilead spokesperson. Senior state officials said they plan to wait for the Drug Controller General of India(DCGI) to approve Indian and foreign companies before initiating a procurement procedure for 10,000 vials.
Consequently, the government said that the decision comes after a revision in the treatment protocol of COVID-19 patients by the Indian Council of Medical Research or ICMR. Remdesivir will be used in only emergency cases and compassionate grounds.
The COVID-19 pandemic has given rise to a lot of potentially dangerous misinformation. For reliable advice on COVID-19 including symptoms, prevention and available treatment, please refer to the World Health Organisation or your national healthcare authority.